Navigation Links
Burg Simpson Files Yasmin/Yaz Lawsuits
Date:7/10/2009

CINCINNATI, July 10 /PRNewswire/ -- Attorneys at BURG SIMPSON ELDREDGE HERSH & JARDINE, P.C. filed four lawsuits this week in federal court against Bayer alleging that Bayer's oral contraceptives Yasmin and Yaz are defective and present an increased risk of injury to women. Three of the suits were filed in Ohio and the fourth in Wisconsin. The four women who filed suit suffered either deep vein thrombosis, pulmonary embolism, and/or stroke while taking these products. In addition, both Yasmin and Yaz have been associated with heart attacks and even death in young women.

The lawsuits allege that Bayer failed to warn the women and their physicians of the increased risk of injury, while over-promoting the benefits of the drugs. In October of 2008, the Food and Drug Administration (FDA) sent Bayer a warning letter objecting to its television ads claiming that Yaz has additional benefits compared to other oral contraceptives. The FDA's letter warned that Yaz actually has additional risks because it contains the progestin drospirenone. The warning prompted an agreement for Bayer to spend $20 million on corrective ads.

Burg Simpson shareholders Michael Burg, Janet Abaray and Seth Katz have vast amounts of experience in litigating dangerous birth control product cases. Mr. Burg and Ms. Abaray currently serve as co-lead counsel in the Ortho Evra Product Liability Litigation, MDL No. 1742. They are leading the firm's Yasmin and Yaz litigation and expect to file additional lawsuits in the coming weeks.

www.burgsimpson.com


'/>"/>
SOURCE Burg Simpson Eldredge Hersh & Jardine, P.C.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Ashlee Simpson to Read Holiday Stories to Children in Hospitals Throughout the Country Premiering Vapps Holiday Storybook Event
2. ev3 Inc. Accepts Resignation of Dr. John Simpson
3. Jessica Simpson Lends Healthy Image for Drink Smart Campaign
4. Alvarado Hospital Files Countersuit Against Blue Shield
5. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
6. Pharsight Files Application for Nasdaq Capital Market Listing
7. Gentiva(R) Health Services Files Universal Shelf Registration Statement
8. Paramount Acquisition Corp. Files Amendment to Preliminary Proxy Statement for Proposed Acquisition of Chem Rx
9. CIGNA Behavioral Health Offers Members Online Provider Profiles
10. American Media Operations, Inc. Files Form 10-Q For First Quarter 2007
11. RxElite Files Registration Statement with Securities and Exchange Commission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... Pittsburgh, PA (PRWEB) , ... May 26, 2016 ... ... transplantation, and one that has a significant negative impact on long-term patient survival, ... to date. The results, published online this week in the Journal of Thoracic ...
(Date:5/26/2016)... ... May 26, 2016 , ... Dr. James ... Fighting Blindness, Long Island Chapter on June 4, 2016, 1:30-3:30 pm at the ... founder of Retina Group of New York , is a Board Certified ...
(Date:5/26/2016)... ... May 26, 2016 , ... Leadership of Life ... announced the organization has earned its ISO 13485 certification, indicating the company’s quality ... all rules and policies associated with ISO quality standard 13485. , BSI ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... offering campers a multitude of activities from daily practices, arts & crafts, discussions, ... Camp Directors Amber East-D’Anna and Christy Evans have combined backgrounds in kids’ yoga, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Power Systems, a leading developer ... Instructor Certification Course in Stoughton, Massachusetts. The course was led by Power Systems’ ... 8 hour interactive course to qualify participants as certified PowerWave trainers. , ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... 25, 2016 ReportsnReports.com adds ... report that provides an overview on therapeutic pipeline ... various stages, therapeutics assessment by drug target, mechanism ... molecule type, along with latest updates, and featured ... players involved in the therapeutic development for Chronic ...
(Date:5/24/2016)... 2016   , Study ... overall bowel cleansing and superiority in , ... of the ascending colon ... Norgine B.V. today announced new positive data from the ... bowel preparation) versus standard 2 litre PEG with ascorbate. The study ...
(Date:5/24/2016)... , May 24, 2016 Celsion ... drug development company, today provided an update on ... escalating clinical trial combining GEN-1, the Company,s DNA-based ... treatment of newly-diagnosed patients with advanced ovarian cancer ... debulking surgery.  GEN-1 is an IL-12 DNA plasmid ...
Breaking Medicine Technology: